| 3 min read
Register for free to listen to this article
Listen with Speechify
0:00
3:00
MILFORD, Mass.—Lookingto simultaneously present a united message to the growing market for cellculture products and services, while also furthering cooperation among a hostof internal divisions, Thermo Fisher Scientific announced in early June thecreation of the Cell Culture Excellence Program. The program looks to leveragea variety of Thermo Fisher brands including, but not limited to, Cellomics,Dharmacon, Pierce, Nunc and Nalgene to provide cell culture products andservices for researchers working in the areas of functional biology, cell-basedtherapeutics and diseases studies.

"The program was launched for a couple of reasons," saysJeff Goldman, marketing manger for the cell culture program. "There is thebrand-building piece, which is necessary because we have many customers who maybe buying products from one brand, but don't have awareness of the full arrayof products and the related applications they serve. Also, our applicationexperts have put together many and will put together more application notes inspecific areas of research to make it easier for our customers to have accessto protocols that are directly relevant to their research."

While the program is aimed at educating life scienceresearchers that they can get most, if not all, of the tools and reagents neededfor cell culture work from a single source, it is apparent the cell cultureprogram is also aimed long-term at creating a working atmosphere at ThermoFisher of greater collaboration between divisions to optimize the breadth ofproducts it has for the ever-growing cell culture segment.

"This program should really help us to talk more among thegroups, from consumables to tools, and sharing more information which willallow us to better help customers with their specific research workflows," saysHeidi McIntosh, product manager for Nunc cell culture and Nalgene filtrationproducts at Thermo Fisher.

The launch of the program and the focus on cell culture alsoappears to be an indication of the long-running integration process withinThermo Fisher, not just from the mega-merger of the two companies in 2006, butof the host of other well-known and respected brands that have been broughtinto the company fold in the past few years.
"We have a historical brand name and there is always a bitof a ramp up," notes Dave Radspinner, director of marketing and customerapplications in cell culture and bioprocessing. "I can tell you of a number oftimes we have been in our branded exhibit booth and a customer will walk up toask what happened to Nalgene and they are standing right next to the Nalgeneline."

The cell culture program, then, helps Thermo Fisher bothreinforce the brand and associate product lines while also presenting to themarket the breadth of products and services the company has across theenterprise to tackle not just single applications, but entire fields ofresearch.
"Customers are always looking for a simplified process ofdoing their work," notes Radspinner. "Rather than working with 15 differentvendors to get everything they need, they can turn to a single source and thatallows them more time for their research."

Beyond the internal nuts and bolts, the program is beinglaunched at a time when cell culture research is blossoming. In addition,government funding could play a role in helping to drive continued growth.

"We anticipate a strong market and the increasedfunding we are seeing in stem research is good indication of that," saysGoldman. "It is a multi-billion dollar market and, until now, there hasn't beena company able to take a comprehensive approach to this market.'
 

About the Author

Related Topics

Published In

Volume 4 - Issue 7 | July 2008

July 2008

July 2008 Issue

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A 3D rendering of motor neurons lit up with blue, purple, orange, and green coloring showing synapses against a black background.

Improving ALS research with pluripotent stem cell-derived models 

Discover new advancements in modeling amyotrophic lateral sclerosis.

Automating 3D cell selection

Discover precise automated tools for organoid and spheroid handling. 
An illustration of the tumor microenvironment, showing cancer cells, T cells, and nanoparticles interacting within a complex biological system

A closer look at the tumor microenvironment 

New technologies are allowing researchers to delve deeper into the complex tumor landscape.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue